COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders

Authors :: Hannah, Kaminski
Mickael, Gigan
Agathe, Vermorel
Manon, Charrier
Laura, Guirle
Frederic, Jambon
Arthur, Lacapère
Coline, Ménard
Karine, Moreau
Martine, Neau-Cransac
Marine, Novion
Frederique, Pribat
Benjamin, Taton
Sébastien, Borde
Laure, Burguet
Charlie, Martinez
Magali, Jasiek
Pauline, D'Halluin
Marie-Edith, Lafon
Pierre, Merville
Lionel, Couzi
Source :: Kidney International. 102:936-938
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Vaccines
Nephrology
Antibodies, Monoclonal
COVID-19
Humans
Pre-Exposure Prophylaxis
Morbidity
Kidney Transplantation

Full Text Access

Tools